Literature DB >> 15623388

[The overview of the seminar on chronic hepatitis B].

Ji-dong Jia1, Hui Zhuang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15623388

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  8 in total

1.  Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B.

Authors:  Wenmei Fan; Bingyi Shi; Hongshan Wei; Guosheng Du; Shujing Song
Journal:  Virus Genes       Date:  2010-12-16       Impact factor: 2.332

2.  Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects.

Authors:  De-Qing Sun; Hai-Sheng Wang; Mei-Yuan Ni; Ben-Jie Wang; Rui-Chen Guo
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

3.  Clinical characteristics and current management of hepatitis B and C in China.

Authors:  Yong-Tao Sun; Yue-Xin Zhang; Hong Tang; Qing Mao; Xiao-Zhong Wang; Ling-Yi Zhang; Hong Chen; Ying-Na Zhong; Shu-Mei Lin; Da-Zhi Zhang
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

4.  Cancer care in China: A general review.

Authors:  Xj Ma; C Lin; W Zhen
Journal:  Biomed Imaging Interv J       Date:  2008-07-01

5.  Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure.

Authors:  Qi Ling; Xiao Xu; Qiang Wei; Xiaoli Liu; Haijun Guo; Li Zhuang; Jiajia Chen; Qi Xia; Haiyang Xie; Jian Wu; Shusen Zheng; Lanjuan Li
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

6.  Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Xiao-Jun Zhu; Xue-Hua Sun; Zheng-Hua Zhou; Shun-Qing Liu; Hua Lv; Man Li; Lu Li; Yue-Qiu Gao
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

7.  Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients.

Authors:  Long-Shan Ji; Qiu-Tian Gao; Ruo-Wen Guo; Xin Zhang; Zhen-Hua Zhou; Zhuo Yu; Xiao-Jun Zhu; Ya-Ting Gao; Xue-Hua Sun; Yue-Qiu Gao; Man Li
Journal:  J Immunol Res       Date:  2019-01-13       Impact factor: 4.818

8.  Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China.

Authors:  Jing Wang; Qiming Feng; Andrew Tam; Tong Sun; Peijing Zhou; Samuel So
Journal:  BMC Med Educ       Date:  2016-03-08       Impact factor: 2.463
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.